ContraVir Pharmaceuticals Inc (NASDAQ:CTRV) traded up NaN during mid-day trading on Thursday . The stock traded as high as $0.55 and last traded at $0.00. 1,025,158 shares traded hands during trading, an increase of Infinity from the average session volume of 0 shares.

Separately, Maxim Group set a $4.00 price objective on shares of ContraVir Pharmaceuticals and gave the stock a “buy” rating in a research report on Monday, October 30th.

An institutional investor recently raised its position in ContraVir Pharmaceuticals stock. Vanguard Group Inc. increased its holdings in ContraVir Pharmaceuticals Inc (NASDAQ:CTRV) by 17.9% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,414,475 shares of the biopharmaceutical company’s stock after buying an additional 366,192 shares during the period. Vanguard Group Inc. owned 3.79% of ContraVir Pharmaceuticals worth $1,400,000 as of its most recent filing with the Securities and Exchange Commission. 9.93% of the stock is currently owned by institutional investors and hedge funds.

TRADEMARK VIOLATION WARNING: This piece of content was originally reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are accessing this piece of content on another website, it was illegally copied and reposted in violation of international trademark & copyright laws. The original version of this piece of content can be accessed at

ContraVir Pharmaceuticals Company Profile

Receive News & Ratings for ContraVir Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ContraVir Pharmaceuticals Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.